TriFlo Cardiovascular Inc — Form D/A
TriFlo Cardiovascular Inc of NEWPORT BEACH, CA, a company, filed a Form D amendment with the SEC on 2022-06-16. The offering totals $16.1M, of which $13.8M was reported sold. Industry: Other.
Offering
- Filed: 2022-06-16
- Form: D/A
- Accession: 0001715934-22-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $16.1M
- Amount sold: $13.8M
- Remaining: $2.3M
- Investors: 150
- Date of first sale: 2020-06-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-371587
Issuer
- Name: TriFlo Cardiovascular Inc
- CIK: 0001715934
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 20101 SW BIRCH ST. STE. 120, NEWPORT BEACH, CA, 92660
- Phone: 16269224745
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| CHRISTOPHER C DEWEY | Director | Sunrise, FL |
| Aldo C Maccari | Director | Newport Beach, CA |
| Daniel C Mahnert-Lueg | Director | Newport Beach, CA |
| Luca Pesce | Director | Newport Beach, CA |
| Stephane C Piat | Director | Newport Beach, CA |
| Kunal C Sarkar | Director | Newport Beach, CA |
| John Paul C Ussia | Director | Newport Beach, CA |
| Luca Pesce | Executive Officer | Newport Beach, CA |
| Elton Satusky | Executive Officer | Palo Alto, CA |
| Thierry Thaure | Director | San Jose, CA |
| Thierry Thaure | Executive Officer | San Jose, CA |
| Stephane Piat | Director | Neuilly sur Seine, I0 |
| William Dangelo | Executive Officer | Beverly Hills, CA |
Other filings by this issuer (6)
More